Determine the weight of the horse. Remove syringe tip. Turn the dial ring until the edge of the ring nearest the tip lines up with the correct weight marking. Depress plunger to advance paste to tip. Set the dial ring at the graduation nearest the weight of the horse for the dosage rate of 5 mg/kg. For the dosage rate of 10 mg/kg, set the dial ring at two times (double) the horse’s weight. Horse’s mouth should be ...
www.strideguardpet.comPaste 10% (100 mg/g)
HORSE DEWORMER
INGREDIENTS: Fenbendazole…..10% (100mg/g)
StrideGuard® (fenbendazole) Paste 10% contains the active anthelmintic, fenbendazole. The chemical name of fenbendazole is methyl 5-(phenylthio)-2-benzimidazole carbamate
The chemical structure is:
Each gram of StrideGuard® Paste 10% contains 100 mg of fenbendazole and is flavored with artificial apple-cinnamon liquid.
The antiparasitic action of Fenivox® Paste 10% is believed to be due to inhibition of energy metabolism in the parasite.
Fenivox® Paste 10% is indicated for the treatment and control of: Large strongyles (Strongylus edentatus, S. equinus, S. vulgaris) Encysted early 3rd stage (hypobiotic), late 3rd stage and 4th stage cyathostome larvae Small strongyles Pinworms (Oxyuris equi) Ascarids (Parascaris equorum) and for the control of arteritis caused by 4th stage larvae of Strongylus vulgaris in horses.
Side effects associated with StrideGuard® Paste 10% could not be established in well-controlled safety studies in horses with single doses as high as 454 mg/lb (1,000 mg/kg) and 15 consecutive daily doses of 22.7 mg/lb (50 mg/kg).Particularly with higher doses, the lethal action of fenbendazole may cause the release of antigens by the dying parasites. This phenomenon may result in either a local or systemic hypersensitivity reaction. As with any drug, these reactions should be treated symptomatically. StrideGuard® Paste 10% has been evaluated for safety in pregnant mares during all stages of gestation with doses as high as 11.4 mg/lb (25 mg/kg) and in stallions with doses as high as 11.4 mg/lb (25 mg/kg). No adverse effects on reproduction were detected. The recommended dose for control of 4th stage Strongylus vulgaris larvae, 4.6 mg/lb (10 mg/kg) daily for 5 consecutive days, has not been evaluated for safety in stallions or pregnant mares.
For foals and weanlings (less than 18 months of age) where ascarids are a common problem, the recommended dose is:4.6 mg/lb (10 mg/kg); one syringe will deworm a 550 lb horse, For the control of large strongyles, small strongyles, and pinworms, the recommended dose is:2.3 mg/lb (5 mg/kg).For control of hypobiotic (encysted early 3rd stage), late 3rd stage, and 4th stage cytostome larvae, 4th stage Strongyles vulgaris larvae, the recommended dose is:4.6 mg/lb (10 mg/kg) daily for 5 consecutive days; administer one syringe for each 550 lb body weight per day. Do not under dose. Ensure each animal receives a complete dose based on a current body weight. Under dosing may result in ineffective treatment and encourage the development of parasite resistance.
WARNINGS: Not for use in humans. Keep this and all drugs out of reach of children. Refrain from smoking or eating while handling. Wash hands after use. Avoid contact with eyes.
OTHER WARNINGS: Do not use in horses intended for human consumption. Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers. Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance. Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method). A decrease in a drug's effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.
Fenivox® Paste 10% Equine Dewormer is supplied in 25 gram syringes.
Store at 20°–25°C (68°–77°F).
Protect from excessive heat and freezing.
Distributed by:
YASMEEN GLOBAL TRADERS LLC
30 N Gould St Ste 53477
Sheridan, WY 82801 USA
Email: Contact@strideguardpet.com
Website: www.strideguardpet.com
NDC 86244-201-01
Fenivox®
Fenbendazole
Equine Dewormer Paste
25 g (0.88 oz)
Paste 10% (100 mg/g)
Broad-Spectrum Parasite Control
Treats & Controls:
Large Strongyles, Small Strongyles,
Ascarids, Pinworms, and Lungworms
Effective:
Broad-spectrum internal parasite protection
Easy to Use:
Convenient 25 g paste syringe for horses
Apple Flavor
FOR ANIMAL USE ONLY
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 86244-201 | 86244-201-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| FENBENDAZOLE | 621BVT9M36 | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2026-06-09 | daily-update | 2026-06-11 05:11:08 |
Adverse event summaries are temporarily unavailable. Other product information remains available.